Möchten Sie immer auf dem neuesten Stand bleiben?

SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...

PRINCETON, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...

ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami,...

Surrozen to Present at Upcoming Healthcare Investor Conference

VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today...

Myriad announced select unaudited preliminary results for the 4th quarter and full year ended Dec. 31, 2025, provided full year 2026 financial guidance.

Sam Raha, president and CEO of Myriad, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Jan. 14, at 5:15 pm PT.

InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

Alignment Healthcare, Inc. (NASDAQ: ALHC) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, at 10:30 a.m. PST.

Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference